COMPARISON OF A NEW FORMULATION OF GOSERELIN (Pepti 3.6 mg) to Zoladex® 3.6 mg

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The comparator drug (Zoladex 3.6 mg) is approved for use as a thinning agent for the endometrium prior to endometrial ablation. The dosing recommendation is one or two depots with each depot given four weeks apart. When two depots are administered, surgery should be performed within two to four weeks following administration of the second depot.
Epistemonikos ID: 0224f8826b176e16fae5826fdb20e40371272c91
First added on: May 07, 2024